Exam: Elite 2026/2027 Test
Bank Protocol
PART I: THE PRIMER
Mastering high-acuity medical-surgical nursing transforms the amateur into the apex clinical
leader capable of averting multi-system failure. The 2026/2027 standard demands zero
hesitation, replacing academic memorization with absolute physiological command.
● The "Panic Button" Cheat Sheet:
○ Sepsis (2026): Shock (MAP < 65 or Lactate ≥ 4) triggers the STAT 1-Hour Bundle;
deploy peripheral norepinephrine immediately; do not wait for central access.
○ Burns: Initiate the Rule of 10s (TBSA × 10 mL/hr); abandon static formulas and
titrate hourly to a 30–50 mL/hr urine output.
○ Stroke: Tenecteplase (TNK) 0.25 mg/kg is the standard rapid 5-second bolus;
execute direct-to-thrombectomy protocols.
○ Heart Failure: SGLT2 inhibitors and ARNis are foundational across all ejection
fractions; initiate simultaneously.
○ Neuro: Level the External Ventricular Drain (EVD) transducer precisely to the
tragus (Foramen of Monro) to prevent lethal herniation.
PART II: THE ELITE TEST BANK
Questions 1–15: Foundational Syntax & Application
Q1: A client is admitted with suspected sepsis. Vital signs reveal a MAP of 61 mmHg and
a serum lactate of 4.5 mmol/L. According to the 2026 Surviving Sepsis Campaign (SSC)
guidelines, which intervention must the nurse execute first? A) Administer a 30 mL/kg IV
crystalloid bolus and await central line placement for vasopressors. B) Initiate broad-spectrum
antimicrobials within 3 hours to allow time for diagnostic imaging. C) Deploy peripheral
norepinephrine immediately via a large-bore antecubital intravenous line. D) Administer the
qSOFA screening tool to confirm the diagnosis of septic shock.
● The Answer: C (Deploy peripheral norepinephrine immediately).
● Distractor Analysis: Option A is lethal; waiting for central access delays life-saving
perfusion and risks permanent multi-organ failure. Option B is incorrect because a MAP
<65 and lactate ≥4 trigger the STAT 1-hour bundle, not the 3-hour bundle reserved for
stable "possible" sepsis. Option D is obsolete; the 2021/2026 SSC explicitly advises
against using qSOFA as a single screening tool.
● The Mentor's Analysis: This is the "Hard Deck" of perfusion. A MAP below 65 mmHg
combined with an elevated lactate indicates profound tissue hypoxia and vasoplegia.
Reversing vasoplegia instantly is your apex priority. The 2026 standard mandates the
, immediate administration of peripheral vasopressors to force perfusion gradients while
fluid resuscitation is simultaneously ongoing. Time is tissue.
Q2: A 70 kg client suffers deep partial-thickness burns to 40% of their Total Body Surface
Area (TBSA). Utilizing the 2026 ABA Rule of 10s protocol, what is the initial hourly
crystalloid resuscitation rate? A) 400 mL/hr B) 280 mL/hr C) 560 mL/hr D) 800 mL/hr
● The Answer: A (400 mL/hr).
● Distractor Analysis: Option B attempts to use outdated Parkland math without properly
converting to hourly rates. Option C incorrectly adds arbitrary weight variables for a
patient under 80kg. Option D doubles the required starting rate, guaranteeing
"resuscitation morbidity" and compartment syndrome.
● The Mentor's Analysis: The 2026 American Burn Association standard utilizes the Rule
of 10s to calculate the starting rate, simplifying cognitive load during initial trauma
stabilization.
Patient Weight Rule of 10s Calculation Example (40% TBSA)
40 kg - 80 kg % TBSA × 10 = mL/hr 40 × 10 = 400 mL/hr
> 80 kg (% TBSA × 10) + 100 mL for N/A for 70 kg
every 10kg > 80kg
Q3: A client arrives with acute ischemic stroke symptoms. Symptom onset was 2 hours
ago. The provider prescribes the 2026 standard thrombolytic. Which medication and
administration protocol should the nurse anticipate? A) Alteplase (tPA) via a 60-minute
continuous infusion. B) Tenecteplase (TNK) 0.25 mg/kg via a single 5-second IV bolus. C)
Heparin via continuous IV infusion titrated to aPTT. D) Dual Antiplatelet Therapy (DAPT)
initiated before CT imaging.
● The Answer: B (Tenecteplase 0.25 mg/kg via 5-second bolus).
● Distractor Analysis: Option A is the pre-2026 old standard; while occasionally used,
TNK is the preferred agent for its pharmacokinetic superiority and rapid administration.
Option C is contraindicated in acute ischemic stroke protocols. Option D is fatal; you
never administer antithrombotics before ruling out a hemorrhagic stroke via CT.
● The Mentor's Analysis: "Time is Brain." TNK is a genetically modified tPA that allows for
a one-and-done 5-second push. This eliminates the need for infusion pumps during
transport, specifically enabling the 2026 "Direct-to-Thrombectomy" (Mothership) model
where EMS bypasses smaller facilities to get the patient to a surgical suite instantly.
Q4: You are reviewing the discharge orders for a client with Heart Failure with reduced
Ejection Fraction (HFrEF). The 2026 Guideline-Directed Medical Therapy (GDMT)
mandates which combination of medications to be initiated early and simultaneously? A)
ACE inhibitor and loop diuretic only. B) Beta-blocker and Digoxin. C) SGLT2 inhibitor and
Angiotensin Receptor-Neprilysin Inhibitor (ARNi). D) Calcium channel blocker and Nitrate.
● The Answer: C (SGLT2 inhibitor and ARNi).
● Distractor Analysis: Option A relies on outdated stepwise titration models. Option B
uses Digoxin, which is no longer first-line due to toxicity risks. Option D utilizes
medications that do not reduce mortality in standard HFrEF.
● The Mentor's Analysis: The 2026 HF guidelines abandoned the slow, multi-year
stepwise titration of ACE inhibitors. GDMT now requires rapid optimization. SGLT2
inhibitors (like empagliflozin) and ARNis (sacubitril/valsartan) provide immediate mortality
reduction, cardiovascular protection, and renal preservation. You do not wait to maximize
one drug before starting the other.
Q5: A client with COPD presents to the clinic. They report one moderate exacerbation in
, the past 12 months requiring systemic steroids. Their blood eosinophil count is 350
cells/µL. Under the 2026 GOLD guidelines, how does this single exacerbation alter their
management? A) It requires no change; continue SABA PRN. B) Reclassifies them to Group E,
requiring an ICS + LABA + LAMA combination. C) Reclassifies them to Group B, requiring
LAMA monotherapy. D) Triggers an immediate referral for lung volume reduction surgery.
● The Answer: B (Reclassifies them to Group E, requiring ICS + LABA + LAMA).
● Distractor Analysis: Option A ignores the exacerbation and relies on outdated models.
Option C ignores the high eosinophil count which dictates ICS use. Option D is an
extreme surgical intervention not indicated for a single exacerbation.
● The Mentor's Analysis: Prior to 2026, it took two exacerbations to move a patient into
the high-risk category. The new GOLD guidelines acknowledge that even one moderate
exacerbation fundamentally changes the disease trajectory, moving them to Group E.
Because the eosinophils are ≥ 300 cells/µL, an Inhaled Corticosteroid (ICS) must be
added to the dual bronchodilator therapy to control the biological inflammation.
Q6: A client is diagnosed with Diabetic Ketoacidosis (DKA). Current blood glucose is 450
mg/dL, and serum potassium is 3.1 mEq/L. The provider orders a continuous regular
insulin infusion. What is the nurse's absolute priority action? A) Initiate the insulin infusion
immediately to correct the hyperglycemia. B) Administer sodium bicarbonate to reverse the
acidosis. C) Withhold the insulin and notify the provider to prescribe IV potassium replacement
first. D) Administer a 50% Dextrose (D50) IV push to prevent a hypoglycemic crash.
● The Answer: C (Withhold insulin and replace potassium first).
● Distractor Analysis: Option A will kill the patient; insulin drives potassium into the cells,
exacerbating hypokalemia and causing lethal arrhythmias. Option B is rarely indicated
(only if pH < 6.9) and worsens intracellular acidosis. Option D is absurd given the BG of
450.
● The Mentor's Analysis: The "Hard Deck" of DKA: Never start insulin if the potassium is <
3.3 mEq/L. Insulin acts as a key, unlocking the cell door to push both glucose and
potassium inside. If the serum potassium is already low, insulin will drop it to fatal levels,
triggering ventricular fibrillation. Correct the K+ before you touch the insulin drip.
Q7: A client with Chronic Kidney Disease (CKD) presents with a serum potassium of 7.2
mEq/L and peaked T-waves on the ECG. What is the immediate pharmacological
intervention to avert cardiac arrest? A) IV Sodium Polystyrene Sulfonate (Kayexalate). B) IV
Calcium Gluconate. C) IV Regular Insulin and Dextrose. D) IV Furosemide.
● The Answer: B (IV Calcium Gluconate).
● Distractor Analysis: Option A takes hours to work via the GI tract. Option C shifts
potassium but does not immediately protect the heart. Option D is too slow and depends
on renal function, which is compromised in CKD.
● The Mentor's Analysis: When you see peaked T-waves, the myocardium is highly
irritable and seconds away from ventricular tachycardia. Calcium gluconate (or calcium
chloride) acts as an immediate physiological shield, stabilizing the cardiac cell membrane
threshold. It does not lower potassium; it simply buys you the 30 minutes you need to
administer insulin/dextrose to safely shift the potassium intracellularly.
Q8: A client presents with severe symptomatic hyponatremia (Serum Na+ 114 mEq/L).
The provider orders 3% Hypertonic Saline. To prevent Osmotic Demyelination Syndrome
(ODS), the nurse ensures the sodium level does not increase by more than how many
mmol/L in a 24-hour period? A) 2 mmol/L B) 8 mmol/L C) 15 mmol/L D) 20 mmol/L
● The Answer: B (8 mmol/L).
● Distractor Analysis: Option A is too conservative and will not resolve cerebral edema.